Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1989-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1136/jnnp.52.1.67PMID 2540286PMCID PMC1032659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffuse Lewy body disease

  2004cited by this paper
• Lewy bodies are ubiquitinated

  1988cited by this paper
• A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin.

  1988cited by this paper
• Ubiquitin-mediated pathways for intracellular proteolysis.

  1987cited by this paper
• The Lewy body in Parkinson's disease.

  1987cited by this paper
• Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies.

  1987cited by this paper
• Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).

  1987cited by this paper
• Analysis of cerebellar motor disorders by visually-guided elbow tracking movement. 2. Contribution of the visual cues on slow ramp pursuit.

  1987cited by this paper
• The Lewy body in Parkinson's disease.

  1987cited by this paper
• Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments.

  1986cited by this paper
• The ubiquitin system: functions and mechanisms

  1985cited by this paper
• Lewy bodies of Parkinson's disease contain neurofilament antigens.

  1983cited by this paper
• Lewy bodies in cerebral cortex. Report of three cases

  1978cited by this paper

• α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies

  2024cites this paper
• Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts

  2024cites this paper
• Alpha Synuclein: Neurodegeneration and Inflammation

  2023cites this paper
• SAR Study of Niclosamide Derivatives for Neuroprotective Function in SH-SY5Y Neuroblastoma.

  2023cites this paper
• Is there a role of insulin degrading enzyme in Parkinson’s disease?

  2022cites this paper
• Elevated Monoamine Oxidase-A in Anterior Cingulate of Post-Mortem Human Parkinson’s Disease: A Potential Surrogate Biomarker for Lewy Bodies?

  2022cites this paper
• Parkinson's disease

  2021cites this paper
• NRM 2021 Abstract Booklet

  2021cites this paper
• Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.

  2020cites this paper
• Pathways of protein synthesis and degradation in PD pathogenesis.

  2020cites this paper
• Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder

  2018cites this paper
• Structural Remodeling of Alpha-Synuclein by Small Molecules: A Novel Path to Neuroprotective Therapeutics

  2018cites this paper
• Difference of recovery course of motor weakness according to state of corticospinal tract in putaminal hemorrhage.

  2017cites this paper
• [Neuropathology and pathophysiology of Parkinson's disease: Focus on α-synuclein].

  2017cites this paper
• An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.

  2016cites this paper
• Protein Structure Modeling of Abnormal Genes Associated with PARK 1 and PARK 8 Loci Related to Autosomal Dominant Parkinson’s Disease and Docking the Protein(s) with Appropriate Ligands

  2016cites this paper
• Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents

  2015influential citation
• Topographical differences in stress vulnerability in experimental Parkinson's disease

  2015cites this paper
• Identification of parkin interactions: implications for Parkinson’s disease

  2015cites this paper
• Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration

  2015cites this paper
• Mitochondrial complex I defects increase ubiquitin in substantia nigra.

  2015cites this paper
• Tesis doctoral UTILIDAD DE LA GAMMAGRAFÍA DE INERVACIÓN MIOCÁRDICA CON 123I-MIBG EN EL DIAGNÓSTICO CLÍNICO DE LA DEMENCIA DE CUERPOS DE LEWY

  2014cites this paper
• Cortical Lewy Body DeInentia

  2014cites this paper
• Synchrotron-based infrared spectroscopy brings to light the structure of protein aggregates in neurodegenerative diseases

  2014cites this paper
• Pneumocyte injury and ubiquitin-positive pneumocytes in interstitial lung diseases*

  2014cites this paper
• Clinicopathologic Study of Alzheimer's Disease: Alzheimer Mimics

  2013cites this paper
• Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration

  2013cites this paper
• Transcriptional regulation by nicotine in dopaminergic neurons.

  2013cites this paper
• Molecular biomarkers of neurodegeneration

  2013cites this paper
• RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis

  2013cites this paper
• Protein degradation pathways in Parkinson’s disease: curse or blessing

  2012cites this paper
• Tyrosine hydroxylase and Lewy body molecules immunoreactivity in the SNC neurons of an AS/AGU mutantrat

  2012cites this paper
• Disruption of protein quality control in Parkinson's disease.

  2012cites this paper
• 인간 신경 줄기세포 HB1.F3에서 alpha-synuclein과 synphilin-1 유전자 전이를 통한 봉입체 형성과 세포 자멸사

  2012cites this paper
• Dementia in Parkinsonism

  2011cites this paper
• Dementia with Lewy Bodies and Parkinson's Disease Dementia

  2011cites this paper
• Parkinson's disease, proteins, and prions: Milestones

  2011cites this paper
• The role of alpha synuclein in Parkinson’s disease

  2011cites this paper
• α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies

  2011cites this paper
• UNIVERSITÀ DEGLI STUDI DELL'INSUBRIA Dottorato di ricerca in Neurobiologia XXIII CICLO

  2010cites this paper
• Cell-based analysis of dynamic aspects of molecular mechanism involved in the pathogenesis of Parkinson's disease

  2010cites this paper
• α-Synuclein and neuronal cell death

  2009cites this paper
• Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports.

  2009cites this paper
• Proteomics in human Parkinson's disease research.

  2009cites this paper
• A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.

  2009cites this paper
• Ubiquitin-positive foam cells are identified in the aortic and mitral valves with atherosclerotic involvement.

  2009cites this paper
• α-Synuclein pathology in very elderly Finns : A population-based clinico-neuropathologic and molecular genetic study of Dementia with Lewy bodies

  2009cites this paper
• Molecular interaction between parkin and PINK1 in mammalian neuronal cells.

  2009cites this paper
• Is malfunction of the ubiquitin proteasome system the primary cause of alpha-synucleinopathies and other chronic human neurodegenerative disease?

  2008cites this paper
• 1 The Etiopathogenesis of Parkinson ’ s Disease : Basic Mechanisms of Neurodegeneration C

  2008cites this paper
• Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease

  2007cites this paper
• Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy‐related pathology

  2007cites this paper
• Multiplication of the α-synuclein gene is not a common disease mechanism in Lewy body disease

  2007cites this paper
• Inclusion Body Formation and Apoptotic Cell Death in the Human Neural Stem Cells HB1.F3 Following Gene Transfection of Alpha-Synuclein and Synphilin-1

  2007cites this paper
• Parkin’s substrates and the pathways leading to neuronal damage

  2007cites this paper
• Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.

  2006cites this paper
• Dementia with lewy bodies: therapeutic opportunities and pitfalls.

  2006cites this paper
• Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease.

  2006cites this paper
• Proteasomal dysfunction in sporadic Parkinson's disease

  2006cites this paper
• Immunohistochemical detection of ubiquitin‐positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage

  2006cites this paper
• Convergent Roles of α‐Synuclein, DA Metabolism, and the Ubiquitin‐Proteasome System in Nigrostriatal Toxicity

  2006cites this paper
• Neuropsychological Differentiation of Dementia with Lewy Bodies from Normal Aging and Alzheimer's Disease

  2006cites this paper
• The Alzheimer Variant of Lewy Body Disease: A Pathologically Confirmed Case-Control Study

  2005cites this paper
• The Alzheimer Variant of Lewy Body Disease: A Pathologically Confi rmed

  2005cites this paper
• Criteria for the clinical diagnosis of dementia with Lewy bodies

  2005cites this paper
• Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases

  2005cites this paper
• Alzheimer's disease with and without cerebral infarcts.

  2005cites this paper
• Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?

  2005cites this paper
• The role of alpha-synuclein in neurodegenerative diseases.

  2005cites this paper
• Impact of α-Synuclein Pathology on Aging

  2005cites this paper
• Dementia with Lewy Bodies: Current Concepts

  2005cites this paper
• The role of α-synuclein in neurodegenerative diseases

  2005cites this paper
• A reassessment of the Lewy body.

  2005cites this paper
• New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies

  2004cites this paper
• Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

  2004cites this paper
• Relationships between Lewy bodies and pale bodies in Parkinson's disease

  2004cites this paper
• Lewy-body formation is an aggresome-related process: a hypothesis.

  2004cites this paper
• Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation

  2004cites this paper
• Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease.

  2004cites this paper
• An adult-onset case of sporadic motor neuron disease with basophilic inclusions

  2004cites this paper
• The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease

  2004cites this paper
• Genetics of neurological disorders

  2004cites this paper
• Pick bodies in the locus ceruleus

  2004cites this paper
• Striatonigral degeneration, olivopontocerebellar atrophy and „atypical” Pick disease

  2004cites this paper
• Cognitive issues in Parkinson's disease.

  2004cites this paper
• The correlation between ubiquitin in the brainstem and sleep apnea in SIDS victims.

  2004cites this paper
• Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques

  2004cites this paper
• Advances in the pharmacological management of Parkinson disease.

  2003cites this paper
• Nightmares without atonia as an early symptom of diffuse Lewy bodies disease.

  2003cites this paper
• The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease

  2003cites this paper
• The correlation between tau protein in the brainstem and sleep apnea in SIDS victims.

  2003cites this paper
• Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

  2003cites this paper
• Dementia with Lewy Bodies: Neuropathology

  2002cites this paper
• Genetics of parkinsonism

  2002cites this paper
• Is Dementia with Lewy Bodies the Second Most Common Cause of Dementia?

  2002cites this paper
• Neuroimaging in Dementia with Lewy Bodies: Metabolism, Neurochemistry, and Morphology

  2002cites this paper
• An attempt at evaluating borderline conditions of Parkinson's disease and its preclinical stage on the basis of clinical and morphological correlation.

  2002cites this paper
• Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

  2001cites this paper
• Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies

  2001cites this paper
• Dementia with Lewy Bodies: What Is Its Relationship to Alzheimer’s Disease?

  2001cites this paper